4-butyrolactone has been researched along with Psychoses, Drug in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duketis, E; Holtmann, M; Maier, J; Poustka, F; Radeloff, D; Schirman, S; Wagner, A; Wöckel, L; Zepf, FD | 1 |
| Aaron, CK; Burns, MJ; Greenberg, MJ; Sivilotti, ML | 1 |
1 review(s) available for 4-butyrolactone and Psychoses, Drug
| Article | Year |
|---|---|
[Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Topics: 4-Butyrolactone; Acute Disease; Adolescent; Anesthetics, Intravenous; Antipsychotic Agents; Benzodiazepines; Butylene Glycols; Child; Critical Care; Delusions; Diagnosis, Differential; Drug Interactions; Humans; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
1 other study(ies) available for 4-butyrolactone and Psychoses, Drug
| Article | Year |
|---|---|
Pentobarbital for severe gamma-butyrolactone withdrawal.
Topics: 4-Butyrolactone; Adult; Arousal; Autonomic Nervous System Diseases; Emergency Service, Hospital; Female; Humans; Illicit Drugs; Male; Pentobarbital; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Treatment Outcome | 2001 |